Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The role of botulinum neurotoxin in pain management--an ongoing controversy.

× No keyword cloud information.

29 in total

1. Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins.

Authors: M J Welch; J R Purkiss; K A Foster
Journal: Toxicon Date: 2000-02 Impact factor: 3.033

2. Botulinum toxin A in the prophylactic treatment of migraine--a randomized, double-blind, placebo-controlled study.

Authors: S Evers; J Vollmer-Haase; S Schwaag; A Rahmann; I-W Husstedt; A Frese
Journal: Cephalalgia Date: 2004-10 Impact factor: 6.292

3. Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection.

Authors: R L Rosales; K Arimura; S Takenaga; M Osame
Journal: Muscle Nerve Date: 1996-04 Impact factor: 3.217

4. Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study.

Authors: S D Silberstein; H Göbel; R Jensen; A H Elkind; R Degryse; J M C M Walcott; C Turkel
Journal: Cephalalgia Date: 2006-07 Impact factor: 6.292

5. Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.

Authors: Stephen D Silberstein; Stuart R Stark; Sylvia M Lucas; Suzanne N Christie; Ronald E Degryse; Catherine C Turkel
Journal: Mayo Clin Proc Date: 2005-09 Impact factor: 7.616

6. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.

Authors: Ninan T Mathew; Benjamin M Frishberg; Marek Gawel; Rozalina Dimitrova; John Gibson; Catherine Turkel
Journal: Headache Date: 2005-04 Impact factor: 5.887

The role of botulinum neurotoxin in pain management--an ongoing controversy.

1. Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins.

2. Botulinum toxin A in the prophylactic treatment of migraine--a randomized, double-blind, placebo-controlled study.

3. Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection.

4. Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study.

5. Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.

6. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.

7. Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.

8. Mechanism of action of botulinum toxin type A in migraine prevention: a pilot study.

9. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain.

10. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.